BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 32169087)

  • 1. Vasculogenic mimicry in carcinogenesis and clinical applications.
    Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
    J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.
    Li S; Meng W; Guan Z; Guo Y; Han X
    Biomed Pharmacother; 2016 May; 80():127-135. PubMed ID: 27133049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy.
    Haiaty S; Rashidi MR; Akbarzadeh M; Maroufi NF; Yousefi B; Nouri M
    IUBMB Life; 2020 May; 72(5):825-841. PubMed ID: 32026601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
    Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
    Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W; Sun W; Zhu H; Zhang J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways in tumor vasculogenic mimicry.
    Vartanian AA
    Biochemistry (Mosc); 2012 Sep; 77(9):1044-55. PubMed ID: 23157265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
    Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
    Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
    Sun B; Zhang D; Zhao N; Zhao X
    Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
    Zheng N; Zhang S; Wu W; Zhang N; Wang J
    Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
    Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
    Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced research on vasculogenic mimicry in cancer.
    Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
    J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress in vasculogenic mimicry in 
multiple tumors].
    Bai J; Xu Z; Liao C; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors.
    Hernández de la Cruz ON; López-González JS; García-Vázquez R; Salinas-Vera YM; Muñiz-Lino MA; Aguilar-Cazares D; López-Camarillo C; Carlos-Reyes Á
    Front Oncol; 2019; 9():1419. PubMed ID: 31993365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional roles of exosomal long non-coding RNAs in cancer.
    Wang M; Zhou L; Yu F; Zhang Y; Li P; Wang K
    Cell Mol Life Sci; 2019 Jun; 76(11):2059-2076. PubMed ID: 30683984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of cancer stem cells to tumor vasculogenic mimicry.
    Yao XH; Ping YF; Bian XW
    Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculogenic mimicry in head and neck tumors: a narrative review.
    Yue Y; Lou Y; Liu X; Peng X
    Transl Cancer Res; 2021 Jun; 10(6):3044-3052. PubMed ID: 35116612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target.
    Treps L; Faure S; Clere N
    Pharmacol Ther; 2021 Jul; 223():107805. PubMed ID: 33465401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
    Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
    J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs: emerging regulators of tumor angiogenesis.
    Sheng SR; Wu JS; Tang YL; Liang XH
    Future Oncol; 2017 Jul; 13(17):1551-1562. PubMed ID: 28513194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.